169 related articles for article (PubMed ID: 38125755)
1. A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer.
Gupta S; Silveira DA; Piedade GPS; Ostrowski MP; Mombach JCM; Hashimoto RF
Noncoding RNA Res; 2024 Mar; 9(1):185-193. PubMed ID: 38125755
[TBL] [Abstract][Full Text] [Related]
2. miR-145-5p Targets Sp1 in Non-Small Cell Lung Cancer Cells and Links to BMI1 Induced Pemetrexed Resistance and Epithelial-Mesenchymal Transition.
Chang WW; Wang BY; Chen SH; Chien PJ; Sheu GT; Lin CH
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499676
[TBL] [Abstract][Full Text] [Related]
3. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer.
Cui Y; Li G; Zhang X; Dai F; Zhang R
Oncol Lett; 2018 Oct; 16(4):4821-4828. PubMed ID: 30250547
[TBL] [Abstract][Full Text] [Related]
4. JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer.
Zhang J; Wang M; Wang J; Wang W
Cell Death Dis; 2022 Jan; 13(1):65. PubMed ID: 35046387
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis.
Chen W; Tan X; Yang Q; Fang Z; Xu Y
Cell Signal; 2022 Jun; 94():110326. PubMed ID: 35367362
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
Wu C; Lin W; Fu F
Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 Promotes Cell Tumorigenicity Through Regulating miR-515-5p/EEF2 Axis in Non-Small Cell Lung Cancer.
Rong F; Liu L; Zou C; Zeng J; Xu Y
Cancer Manag Res; 2020; 12():7691-7701. PubMed ID: 32943920
[TBL] [Abstract][Full Text] [Related]
9. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis.
Tuo Z; Liang L; Zhou R
J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
[TBL] [Abstract][Full Text] [Related]
10. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
[TBL] [Abstract][Full Text] [Related]
11. BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness.
Shen HT; Chien PJ; Chen SH; Sheu GT; Jan MS; Wang BY; Chang WW
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726929
[TBL] [Abstract][Full Text] [Related]
12. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death.
Gupta S; Silveira DA; Mombach JCM; Hashimoto RF
Noncoding RNA Res; 2023 Dec; 8(4):605-614. PubMed ID: 37767112
[TBL] [Abstract][Full Text] [Related]
15. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
Gupta S; Hashimoto RF
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.
Wu X; Tan Y; Tang X
Biomed Res Int; 2022; 2022():8093949. PubMed ID: 35601153
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis.
Wang Y; Wang X; Han L; Hu D
Cancer Manag Res; 2020; 12():9999-10010. PubMed ID: 33116856
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 Aggravates the Progression of Non-Small Cell Lung Cancer by Stimulating the Expression of COMMD8 via Targeting miR-613.
Wang S; Wang T; Liu D; Kong H
Cancer Manag Res; 2020; 12():10735-10747. PubMed ID: 33149680
[TBL] [Abstract][Full Text] [Related]
19. lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via Down-Regulating miR-202 Expression.
Tiansheng G; Junming H; Xiaoyun W; Peixi C; Shaoshan D; Qianping C
Cell J; 2020 Oct; 22(3):375-385. PubMed ID: 31863664
[TBL] [Abstract][Full Text] [Related]
20. MALAT1-miR-30c-5p-CTGF/ATG5 axis regulates silica-induced experimental silicosis by mediating EMT in alveolar epithelial cells.
Xia J; Tian Y; Shao Z; Li C; Ding M; Qi Y; Xu X; Dai K; Wu C; Yao W; Hao C
Ecotoxicol Environ Saf; 2023 Jan; 249():114392. PubMed ID: 36508811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
